Article
Comparative molecular dynamics analyses on PIK3CA hotspot mutations with PI3Kα specific inhibitors and ATP.
Computational biology and chemistry - 1 Aug 2022
Menteş Muratcan, Karakuzulu Başak Buse, Uçar Gönlüm Bahar, Yandım Cihangir
Abstract excerpt
PI3K pathway is heavily emphasized in cancer where PIK3CA, which encodes for the p110α subunit of PI3Kα, presents itself as the second most common mutated gene. A lot of effort has been put in developing PI3K inhibitors, opening promising avenues for the treatment of cancer. Among these, PI3Kα specific inhibitor alpelisib was approved by FDA for breast cancer and other α-isoform specific inhibitors such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
